Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study
- PMID: 26139439
- PMCID: PMC4731126
- DOI: 10.1681/ASN.2015020152
Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study
Abstract
Childhood chronic kidney disease (CHD) poses multiple threats to bone accrual; however, the associated fracture risk is not well characterized. This prospective cohort study included 537 CKD in Children (CKiD) participants. Fracture histories were obtained at baseline, at years 1, 3, and 5 through November 1, 2009, and annually thereafter. We used Cox regression analysis of first incident fracture to evaluate potential correlates of fracture risk. At enrollment, median age was 11 years, and 16% of patients reported a prior fracture. Over a median of 3.9 years, 43 males and 24 females sustained incident fractures, corresponding to 395 (95% confidence interval [95% CI], 293-533) and 323 (95% CI, 216-481) fractures per 10,000 person-years, respectively. These rates were 2- to 3-fold higher than published general population rates. The only gender difference in fracture risk was a 2.6-fold higher risk in males aged ≥15 years (570/10,000 person-years, adjusted P=0.04). In multivariable analysis, advanced pubertal stage, greater height Z-score, difficulty walking, and higher average log-transformed parathyroid hormone level were independently associated with greater fracture risk (all P≤0.04). Phosphate binder treatment (predominantly calcium-based) was associated with lower fracture risk (hazard ratio, 0.37; 95% CI, 0.15-0.91; P=0.03). Participation in more than one team sport was associated with higher risk (hazard ratio, 4.87; 95% CI, 2.21-10.75; P<0.001). In conclusion, children with CKD have a high burden of fracture. Regarding modifiable factors, higher average parathyroid hormone level was associated with greater risk of fracture, whereas phosphate binder use was protective in this cohort.
Keywords: children; chronic kidney disease; clinical epidemiology.
Copyright © 2016 by the American Society of Nephrology.
Figures
Comment in
-
Chronic kidney disease-mineral and bone disorder: Fracture burden in children with CKD.Nat Rev Nephrol. 2015 Sep;11(9):505. doi: 10.1038/nrneph.2015.120. Epub 2015 Jul 21. Nat Rev Nephrol. 2015. PMID: 26195147 No abstract available.
-
Declining Hip Fracture Rates in Dialysis Patients: Is This Winning the War?Am J Kidney Dis. 2018 Feb;71(2):154-156. doi: 10.1053/j.ajkd.2017.10.007. Am J Kidney Dis. 2018. PMID: 29389383 No abstract available.
Similar articles
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
-
Incidence of fractures in middle-aged individuals with early chronic kidney disease: a population-based analysis of CARTaGENE.Nephrol Dial Transplant. 2020 Oct 1;35(10):1712-1721. doi: 10.1093/ndt/gfz259. Nephrol Dial Transplant. 2020. PMID: 31951261
-
Skeletal manifestations of renal disease in childhood.Curr Opin Nephrol Hypertens. 2016 Jul;25(4):292-300. doi: 10.1097/MNH.0000000000000233. Curr Opin Nephrol Hypertens. 2016. PMID: 27219042 Review.
-
Cardiac Biomarkers are Associated with Incident Fracture Risk in Advanced Chronic Kidney Disease.Calcif Tissue Int. 2024 Nov;115(5):516-524. doi: 10.1007/s00223-024-01275-4. Epub 2024 Aug 20. Calcif Tissue Int. 2024. PMID: 39164372 Free PMC article.
-
Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease.J Bone Miner Res. 2021 Feb;36(2):298-304. doi: 10.1002/jbmr.4182. Epub 2020 Oct 23. J Bone Miner Res. 2021. PMID: 32960469 Free PMC article.
Cited by
-
Hyperparathyroidism Is an Independent Risk Factor for Allograft Dysfunction in Pediatric Kidney Transplantation.Kidney Int Rep. 2022 Oct 28;8(1):81-90. doi: 10.1016/j.ekir.2022.10.018. eCollection 2023 Jan. Kidney Int Rep. 2022. PMID: 36644359 Free PMC article.
-
Nutritional management of the infant with chronic kidney disease stages 2-5 and on dialysis.Pediatr Nephrol. 2023 Jan;38(1):87-103. doi: 10.1007/s00467-022-05529-x. Epub 2022 Apr 5. Pediatr Nephrol. 2023. PMID: 35378603 Free PMC article. Review.
-
Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy.Nutrients. 2023 Sep 25;15(19):4127. doi: 10.3390/nu15194127. Nutrients. 2023. PMID: 37836411 Free PMC article.
-
Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25. Pediatr Nephrol. 2024. PMID: 37624528 Free PMC article.
-
Renal osteodystrophy: something old, something new, something needed.Curr Opin Nephrol Hypertens. 2023 Nov 1;32(6):559-564. doi: 10.1097/MNH.0000000000000918. Epub 2023 Aug 8. Curr Opin Nephrol Hypertens. 2023. PMID: 37753646 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
- U01 DK082194/DK/NIDDK NIH HHS/United States
- U01 DK066143/DK/NIDDK NIH HHS/United States
- U01 DK066116/DK/NIDDK NIH HHS/United States
- U01 DK066174/DK/NIDDK NIH HHS/United States
- U01-DK66143/DK/NIDDK NIH HHS/United States
- K23-DK084339/DK/NIDDK NIH HHS/United States
- U01-DK82194/DK/NIDDK NIH HHS/United States
- U01-DK66116/DK/NIDDK NIH HHS/United States
- K23 DK093556/DK/NIDDK NIH HHS/United States
- U01-DK66174/DK/NIDDK NIH HHS/United States
- K24-DK076808/DK/NIDDK NIH HHS/United States
- K23 DK084339/DK/NIDDK NIH HHS/United States
- K23-DK093556/DK/NIDDK NIH HHS/United States
- K24 DK078737/DK/NIDDK NIH HHS/United States
- K24 DK076808/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical